|
IBTK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.162180E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.587300E-04 |
| Normal-vs-Stage2 |
5.900400E-02 |
| Normal-vs-Stage3 |
1.66695999999078E-05 |
| Normal-vs-Stage4 |
3.170900E-04 |
| Stage1-vs-Stage2 |
9.287400E-01 |
| Stage1-vs-Stage3 |
1.652030E-01 |
| Stage1-vs-Stage4 |
3.567800E-01 |
| Stage2-vs-Stage3 |
4.478000E-01 |
| Stage2-vs-Stage4 |
5.599000E-01 |
| Stage3-vs-Stage4 |
8.155000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.79600000000035E-05 |
| Normal-vs-AfricanAmerican |
5.213700E-04 |
| Normal-vs-Asian |
9.586200E-02 |
| Caucasian-vs-AfricanAmerican |
7.056800E-01 |
| Caucasian-vs-Asian |
8.372800E-01 |
| AfricanAmerican-vs-Asian |
9.687200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1300999999706E-06 |
| Normal-vs-Female |
9.456100E-03 |
| Male-vs-Female |
9.775600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.416730E-04 |
| Normal-vs-Age(41-60Yrs) |
7.164300E-04 |
| Normal-vs-Age(61-80Yrs) |
4.20840000000533E-05 |
| Normal-vs-Age(81-100Yrs) |
1.036580E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.475170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.139450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.213000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.782200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.057800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.926000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.553800E-01 |
| Normal-vs-Grade 2 |
4.815100E-03 |
| Normal-vs-Grade 3 |
1.57852000000069E-05 |
| Normal-vs-Grade 4 |
2.25440000001242E-08 |
| Grade 1-vs-Grade 2 |
3.949600E-01 |
| Grade 1-vs-Grade 3 |
1.428970E-01 |
| Grade 1-vs-Grade 4 |
8.117200E-03 |
| Grade 2-vs-Grade 3 |
8.268300E-02 |
| Grade 2-vs-Grade 4 |
8.027600E-04 |
| Grade 3-vs-Grade 4 |
3.982400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.036830E-01 |
| Normal-vs-ccB subtype |
1.36120000049367E-07 |
| ccA subtype-vs-ccB subtype |
1.82157999999433E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.496440E-03 |
| Normal-vs-N1 |
8.314000E-02 |
| N0-vs-N1 |
9.941400E-01 |
|
|
